Postpartum Uterine Artery Doppler Indices when Leaving the Placenta In Situ for Placenta Accreta Spectrum

Abstract

Objectives

This study aimed to evaluate longitudinal changes in uterine artery (UtA) Doppler velocimetry in patients with placenta accreta spectrum (PAS) managed by leaving the placenta in situ (LPIS) postpartum.

Study Design

This is a prospective cohort study of patients with PAS managed by LPIS for either planned interval hysterectomy or uterine preservation who underwent serial postpartum ultrasounds. We included patients who had Doppler velocimetry of the UtA obtained before delivery and postpartum. Left, right, and mean (m) peak systolic velocity (PSV), end-diastolic velocity (EDV), and pulsatility index (PI) were recorded. Our goal is to describe changes in these Doppler indices over time and to make comparisons with normal postpartum reference values.

Results

A total of 34 patients were included: 19 planned for uterine-sparing management and 15 planned for interval hysterectomy. No significant differences in mUtA PI, mPSV, and mEDV were documented between predelivery values and those obtained within the first eight weeks postpartum, however after 8 weeks there was a significant increase in mUtA PI (0.80–1.49; p < 0.001), while mUtA PSV (103.8–58.6 cm/s; p = 0.002) and mEDV (53.5–15.8 cm/s; p < 0.001) decreased significantly. Patients opting for uterine-sparing management who successfully retained their uterus showed a trend for higher mUtA PI, PSV, and EDV than those who underwent an interval hysterectomy. mUtA PI postpartum values were lower in our study group compared to those reported from postpartum patients without PAS.

Conclusion

In comparison to patients without PAS, mUtA PI is markedly lower in LPIS patients in the first 8 weeks. In patients undergoing LPIS for PAS, UtA Doppler indices start to show significant changes at ≥ 8 weeks postpartum compared to predelivery values, with a significant increase in mUtA PI and a reduction in mUtA PSV and EDV. Future studies are needed to evaluate the clinical utility of these findings.

Key Points

• UtA PI is lower when the placenta is left in situ.

• UtA PI increases and velocities decrease after 8 weeks.

• Those who retain their uterus have higher UtA PI.

Keywords

color Doppler - conservative management - Doppler sonography - Doppler velocimetry - placenta accreta spectrum - placenta in situ - uterine artery - uterine preservation

• References

• 1 Usta IM, Hobeika EM, Musa AAA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol 2005; 193 (3 Pt 2): 1045-1049
• 2 Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005; 192 (05) 1458-1461
• 3 Mogos MF, Salemi JL, Ashley M, Whiteman VE, Salihu HM. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011. J Matern Fetal Neonatal Med 2016; 29 (07) 1077-1082
• 4 Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol 2019; 221 (03) 208-218
• 5 Silver RM, Landon MB, Rouse DJ. et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107 (06) 1226-1232
• 6 Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Society of Gynecologic Oncology, American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine. Placenta accreta spectrum. Am J Obstet Gynecol 2018; 219 (06) B2-B16
• 7 Fishel Bartal M, Papanna R, Zacharias NM. et al. Planned versus unplanned delivery for placenta accreta spectrum. Am J Perinatol 2022; 39 (03) 252-258
• 8 Lee PS, Kempner S, Miller M. et al. Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes. Gynecol Oncol Res Pract 2017; 4: 11
• 9 Zuckerwise LC, Craig AM, Newton JM, Zhao S, Bennett KA, Crispens MA. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol 2020; 222 (02) 179.e1-179.e9
• 10 Pineles BL, Sibai BM, Sentilhes L. Is conservative management of placenta accreta spectrum disorders practical in the United States?. Am J Obstet Gynecol MFM 2023; 5 (03) 100749
• 11 Pineles BL, Coselli J, Ghorayeb T. et al. Leaving the placenta in situ in placenta accreta spectrum disorders: a single-center case series. Am J Perinatol 2022; 41 (S01): e420-e429
• 12 Amro FH, Bartal MF, Andrade EH. et al. 70 management approaches for placenta accreta spectrum–not a one size fits all approach. Am J Obstet Gynecol 2024; 230 (01) S52-S53
• 13 Sentilhes L, Seco A, Azria E. et al; PACCRETA Study Group. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol 2022; 226 (06) 839.e1-839.e24
• 14 Esakoff TF, Handler SJ, Granados JM, Caughey AB. PAMUS: placenta accreta management across the United States. J Matern Fetal Neonatal Med 2012; 25 (06) 761-765
• 15 Shainker SA, Coleman B, Timor-Tritsch IE. et al; Society for Maternal-Fetal Medicine. Electronic address: [e-mail]. Special report of the society for maternal-fetal medicine placenta accreta spectrum ultrasound marker task force: consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. Am J Obstet Gynecol 2021; 224 (01) B2-B14
• 16 Mulic-Lutvica A, Eurenius K, Axelsson O. Uterine artery Doppler ultrasound in postpartum women with retained placental tissue. Acta Obstet Gynecol Scand 2009; 88 (06) 724-728
• 17 Guedes-Martins L, Gaio AR, Saraiva J, Cunha A, Macedo F, Almeida H. Uterine artery impedance during the first eight postpartum weeks. Sci Rep 2015; 5 (01) 8786
• 18 Harris PA, Taylor R, Minor BL. et al; REDCap Consortium. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 103208
• 19 Haidar ZA, Papanna R, Sibai BM. et al. Can 3-dimensional power Doppler indices improve the prenatal diagnosis of a potentially morbidly adherent placenta in patients with placenta previa?. Am J Obstet Gynecol 2017; 217 (02) 202.e1-202.e13
• 20 Shih JC, Kang J, Tsai SJ, Lee JK, Liu KL, Huang KY. The “rail sign”: an ultrasound finding in placenta accreta spectrum indicating deep villous invasion and adverse outcomes. Am J Obstet Gynecol 2021; 225 (03) 292.e1-292.e17
• 21 Lu T, Wang L, Li M. et al. Diffusion-derived vessel density (DDVD) computed from a simple diffusion MRI protocol as a biomarker of placental blood circulation in patients with placenta accreta spectrum disorders: a proof-of-concept study. Magn Reson Imaging 2024; 109: 180-186
• 22 Konstantinidou AE, Bourgioti C, Fotopoulos S. et al. Stripped fetal vessel sign: a novel pathological feature of abnormal fetal vasculature in placenta accreta spectrum disorders with MRI correlates. Placenta 2019; 85: 74-77
• 23 Cho HY, Hwang HS, Jung I, Park YW, Kwon JY, Kim YH. Diagnosis of placenta accreta by uterine artery doppler velocimetry in patients with placenta previa. J Ultrasound Med 2015; 34 (09) 1571-1575
• 24 Vahdani FG, Shabani A, Haddadi M. et al. Novel markers of Doppler ultrasonography in the placenta accreta spectrum to predict complications. J Turk Ger Gynecol Assoc 2023; 24 (04) 228-234
• 25 Jauniaux E, D'Antonio F, Bhide A. et al; Delphi consensus expert panel. Modified Delphi study of ultrasound signs associated with placenta accreta spectrum. Ultrasound Obstet Gynecol 2023; 61 (04) 518-525